Negotiated Medicare Drug Prices Could Impact Drugmakers’ Profits and Innovation

Trenton, New Jersey – President Joe Biden’s Inflation Reduction Act includes a crucial policy focusing on Medicare drug-price negotiations to alleviate the burden of expensive medications on seniors. The act aims to make these medications more affordable for the elderly population, potentially impacting drugmakers’ profits. In light of this initiative, final negotiated prices for the initial round of drugs subject to these negotiations, involving companies like J&J and Bristol Myers, are set to take effect …

Read more

PBMs push back against rising drug costs in health care battle

New York, New York – Health care remains a hot topic in the United States, with Pharmacy Benefit Managers (PBMs) at the forefront of attention. PBMs are facing backlash for their role in pricing and accessibility of medications. The fight between stakeholders in the health care industry continues to escalate, with PBMs defending their practices amidst criticism. The complex world of PBMs involves negotiating drug prices with pharmaceutical companies, managing prescription drug benefits for insurers, …

Read more

Regeneron Faces Allegations of False Claims Act Violation in Eye Drug Case

Albany, New York – Regeneron Pharmaceuticals, a biotechnology company based in Tarrytown, New York, is facing accusations of violating the False Claims Act in relation to its eye drug. The allegations suggest that Regeneron engaged in deceptive practices in marketing the medication, raising concerns about potential financial misconduct. The False Claims Act, a federal law aimed at combating fraud against the government, has been invoked to bring to light the alleged misconduct by Regeneron. The …

Read more

Healthcare Clash: Trump vs. Biden on Insurance Coverage, COVID Response, and Drug Prices

Washington, D.C. – The stark contrast between former President Donald Trump and current President Joe Biden on health care issues highlights a key difference between the two major presidential candidates. Over the past four years, Biden has championed the Democratic Party’s longstanding goal of ensuring universal health insurance coverage through government intervention. In contrast, Trump pursued a more traditional GOP approach aimed at dismantling such coverage, ultimately falling short in his efforts. The response to …

Read more

Alleged Drug Mule of Diddy Arrested: Bodycam Footage Captures Glum Reacts

Miami, Florida – A former college basketball player, Brendan Paul, was arrested at Opa Locka Airport in Miami after federal agents intercepted a private jet belonging to music mogul Diddy. Paul, 25, was taken into custody for possession of cocaine and marijuana candy, both classified as felonies in Florida, as reported in an arrest document obtained by The Post on March 28, 2024. In a video captured during his arrest, Paul appeared glum and resigned …

Read more

Prescription Drug Prices in Focus: Trump’s Past Actions Shape Potential Future Impact on Healthcare

Washington, D.C. – Former President Donald Trump sparked controversy when discussing entitlements in a recent interview. Trump’s comments on potential cuts to Social Security and Medicare raised concerns and drew backlash from critics, especially given the sensitive nature of these programs in American politics. In response to the backlash, Trump’s campaign clarified that he was referring to reducing waste and inefficiency, not cutting benefits. However, the remarks highlighted the divisive issue of entitlement reform and …

Read more

Drug Prices in Focus Again as Biden Seeks Credit for Speech

Washington, D.C. – President Biden addressed the nation on Tuesday, advocating for policies aimed at reducing drug prices and improving access to healthcare. In his State of the Union speech, Biden highlighted the need for Congress to take action to address the rising costs of healthcare for Americans across the country. Biden’s speech focused on the urgent need to tackle the issue of escalating drug prices, emphasizing the importance of affordable healthcare for all. He …

Read more

FDA Urged to Strengthen Warnings for Asthma Drug Singulair by New York Attorney General

Albany, New York – The New York attorney general’s office is urging the Food and Drug Administration (FDA) to take stronger actions against the use of an asthma drug known as montelukast, more commonly referred to as Singulair, due to concerns about its potential side effects, particularly in children. The Office of the Attorney General’s Health Care Bureau chief, Darsana Srinivasan, raised concerns in a letter to FDA Commissioner Robert Califf about the existing warnings …

Read more

Medicare Drug Negotiations: Biden’s Big Win in Court

Austin, Texas – President Biden’s win in an early court test for Medicare drug negotiations has brought renewed attention to the issue. The lawsuit was brought by a pharmaceutical group challenging the drug price negotiation program for Medicare. However, a federal judge dismissed the lawsuit, marking a significant victory for the Biden administration’s healthcare agenda. This ruling is seen as a crucial step toward the implementation of Medicare drug price negotiations, which has been a …

Read more

Drug Overdose Deaths Shift from Injections to Smoking, CDC Study Finds as Fentanyl Deaths Surge

Atlanta, Georgia – A recent study conducted by the Centers for Disease Control and Prevention (CDC) has revealed a concerning trend in drug overdose deaths in the United States. The study found that the percentage of overdose deaths related to smoking drugs has spiked, surpassing those related to injections. From 2020-22, the study reported a 73.7 percent increase in overdose deaths linked to smoking drugs, while injection-related deaths decreased by 29.1 percent. This shift in …

Read more